Tickerplace logo

Tickerplace

Nektar Therapeutics logo

NKTRNektar Therapeutics

NKTR Stock Price, Valuation & Chart | Nektar Therapeutics

Compare
$37.220-1.43 (-3.70%)

At close · 23 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

NKTR Historical price chart

NKTR Key Stats

Market Capitalization1.07B
PE Ratio-5.57
EPS-6.68
Trading Volume469.62K
Today's High/Low37.89/36.66
Dividend Yield0.00
52 Week High/Low109.0/33.4
Shares Outstanding28.69M
NKTR Financial Statement
NKTR Analyst ratings
NKTR Analysis & performance metrics

NKTR Company profile

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The…

NKTR Management team

Management
Howard W. RobinCEO
Chief Executive Officer, President & Director
Mark A. Wilson J.D.
Senior Vice President, Chief Legal Officer & Secretary
Jonathan Zalevsky Ph.D.
Senior Vice President and Chief Research & Development Officer
Sandra A. GardinerCFO
Chief Financial Officer and Principal Financial & Accounting Officer
Brian L. Kotzin M.D.
Interim Chief Medical Officer
Jason Barnard
Chief Accounting Officer
Robert Bacci
Chief People Officer and Head of Quality & Facilities
Jennifer Ruddock
Chief Business Officer
Total 8 executives

NKTR Frequently asked questions

What is Nektar Therapeutics (NKTR) Stock Price?

Current stock price of Nektar Therapeutics (NKTR) stock is $37.220. The stock price is -3.70% lower in the session. The intraday range can be seen from this page. Volume of Nektar Therapeutics (NKTR) stock is 469.62K.

Last updated at 23 Oct 2026, 08:00 pm.

Why is the Nektar Therapeutics (NKTR) stock price going up or down today?

The stock price of Nektar Therapeutics (NKTR) can change with earnings, company news, and overall market sentiment. Nektar Therapeutics operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Nektar Therapeutics stock expensive at its current price?

Whether Nektar Therapeutics looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NKTR on this page is -5.57. EPS on this page is -6.68. Compare those figures with peers and growth expectations before deciding if the current Nektar Therapeutics price is justified.

How has the stock price of Nektar Therapeutics (NKTR) performed historically?

Historical performance for Nektar Therapeutics (NKTR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NKTR reacted to past earnings and market events.

Should I buy Nektar Therapeutics (NKTR) stock, at this price?

Buying Nektar Therapeutics (NKTR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.